tiprankstipranks
Trending News
More News >
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market

Allarity Therapeutics (ALLR) Financial Statements

Compare
366 Followers

Allarity Therapeutics Financial Overview

Allarity Therapeutics's market cap is currently $17.50M. The company's EPS TTM is $-0.19; its P/E ratio is -0.65; Allarity Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -27.24M$ -17.13M$ -34.46M$ -26.56M$ -8.32M
EBITDA$ -24.23M$ -11.28M$ -17.30M$ -25.77M$ -6.01M
Net Income$ -24.52M$ -11.90M$ -16.06M$ -26.65M$ -6.60M
Balance Sheet
Cash & Short-Term Investments$ 19.53M$ 166.00K$ 2.03M$ 19.91M$ 298.00K
Total Assets$ 22.65M$ 11.86M$ 14.54M$ 49.63M$ 33.40M
Total Debt$ 1.35M$ 1.30M$ 3.73M$ 1.09M$ 2.67M
Net Debt$ -18.18M$ 1.13M$ 1.71M$ -18.47M$ 2.37M
Total Liabilities$ 10.84M$ 14.61M$ 12.65M$ 30.85M$ 8.96M
Stockholders' Equity$ 11.81M$ -2.75M$ 1.89M$ 18.78M$ 24.44M
Cash Flow
Free Cash Flow$ -17.65M$ -12.74M$ -16.84M$ -15.05M$ -7.25M
Operating Cash Flow$ -17.35M$ -12.74M$ -16.82M$ -15.05M$ -7.25M
Investing Cash Flow$ -298.00K$ 0.00$ 791.00K$ 1.00M$ -3.00K
Financing Cash Flow$ 36.79M$ 10.99M$ -1.31M$ 33.82M$ 6.03M
Currency in USD

Allarity Therapeutics Earnings and Revenue History

Allarity Therapeutics Debt to Assets

Allarity Therapeutics Cash Flow

Allarity Therapeutics Forecast EPS vs Actual EPS